You're in the right place! Welcome to our newly updated ESC website.
Start exploring or use our powerful new search engine to find what you need. 

Plenary meeting "Guidelines implementation" part 2

10 Jul 2024 - 11 Jul 2024
+ 2024-07-10T14:00 2024-07-11T14:00 Europe/Paris Plenary meeting "Guidelines implementation" part 2
Vienna, Austria
Add to calendar 2024-07-10T14:00 2024-07-11T14:00 Europe/Paris Plenary meeting "Guidelines implementation" part 2
CRT Onsite

Objectives of the CRT Meeting 

The May and July CRT meetings aim to discuss implementation science in cardiovascular medicine and define a vision for the promotion and adoption of evidence-based practices by integrating various ESC activities into routine healthcare provision to improve patient outcomes.

The May meeting focused on the barriers that may limit the widespread adoption of the ESC Guidelines and delved into these challenges on the local, regional, and national levels. The group discussed how data collection and educational activities can help identify gaps in implementation and how healthcare systems, socio-economic factors as well as physicians and allied health professionals may impact the adherence to guideline-indicated treatments.

The July meeting discussed innovative mechanisms and quality of care improvement strategies aimed at addressing the ‘evidence-practice’ gap, with the ultimate goal of proposing a comprehensive implementation programme to improve patient care.

Day 1:  10 July 2024  13:30–18:30 CEST 
  • 12:00-13:30 - Arrival and Buffet Lunch
  • 13:30-13:35 - Welcome from the CRT Chairpersons by Alexandra Goncalves (BMS) and Thomas F. Lüscher
  • 13:35-15:30 - SESSION 1.1 – What is implementation science and examples of programs that facilitate quality improvement, moderated by Susanna Price and Alphons Vincent (Medtronic)
  • 15:35-18:30 - SESSION 1.2 – An ESC approach to supporting implementation science and quality of care, moderated by Eva Prescott and Ricardo Rocha (Intellia Therapeutics)
    • 15:35-15:40 - An integrated ESC quality of care programme: putting theory in action (Demonstration Video)
    • 15:40-16:25 - Operationalization of the ESC QoC Programme: from Guidelines to outcomes
      • Susanna Price (Education)
      • Chris Plummer (Exams & accreditation)
      • Stefan James (Registries)
      • Julie Sanders (Outcomes including PROMS)
      • Stephan Windecker (Trials)
      • Felix Tanner (Training)
      • Suleman Aktaa (Quality assessment & programme implementation)
    • 16:25-17:25 - BREAKOUT SESSIONS: Barriers and Solutions to implement an ESC Quality of Care (QoC) Programme
      • Group 1: Systems: National healthcare system, institutional characteristics. Lead: Mirko de Melis (Medtronic), Rapporteur: Thomas Rosemann
      • Group 2: Finance aspects. Lead: Stefan James, Rapporteur: Maria Ripa (Novo Nordisk)
      • Group 3: Physician, allied health professional, patient. Lead: Carlos Eid (Novartis), Rapporteur: Nico Bruining
    • 17:25-17:35 - Report from breakout session 1 by Rapporteur: Thomas Rosemann
    • 17:35-17:45 - Report from breakout session 2 by Rapporteur: Maria Ripa (Novo Nordisk)
    • 17:45-17:55 - Report from breakout session 3 by Rapporteur: Nico Bruining
    • 17:55-18:25 - PANEL DISCUSSION
    • 18:25-18:30 - Wrap-up and summary day 1 – Outlook to day 2 by Alexandra Goncalves (BMS) and Thomas F. Lüscher
  • END OF DAY 1
  • 19:30 - APERITIF + DINNER
Day 2:  11 July 2024  08:20–12:00 CEST

 

Chairpersons

Doctor Ricardo Rocha

Intellia Therapeutics

Photo
Professor Thomas Felix Luescher

ESC President-elect and ESC Chair of the CRT

Mrs Tamara Krcmar

Servier International

Photo
Doctor Alexandra Goncalves

BMS (Industry Chair of the CRT)

Replays

Biographies

Prof. Thomas F. LÜSCHER, UK.pdf (PDF)
Prof. Alexandra GONCALVES, BMS.pdf (PDF)
Dr. Suleman Aktaa, UK.pdf (PDF)
Prof. Folkert ASSELBERGS, Netherlands.pdf (PDF)
Dr. ing. Nico Bruining, Ph.D., Netherlands.pdf (PDF)
Ms. Anne CHEVRIER, France.pdf (PDF)
Dr. Carlos EID, Novartis AG.pdf (PDF)
Prof. Gerhard HINDRICKS, Germany.pdf (PDF)
Prof. Stefan JAMES, Sweden.pdf (PDF)
Dr. Laney JONES, Amgen.pdf (PDF)
Ms. Tamara KRCMAR, Servier Affaires Internationales.pdf (PDF)
Dr. Mirko DE MELIS, Medtronic.pdf (PDF)
Dr. Nándor Ákos NAGY, GE Healthcare.pdf (PDF)
Dr. Chris PLUMMER, UK.pdf (PDF)
Prof. Eva Prescott, Denmark.pdf (PDF)
Prof. Susanna Price, UK.pdf (PDF)
Ms. Tuula RINTALA, EBMT.pdf (PDF)
Dr. Maria Sejersten RIPA, Novo Nordisk.pdf (PDF)
Dr. Ricardo ROCHA, Intellia Therapeutics.pdf (PDF)
Prof. Thomas ROSEMANN, Switzerland.pdf (PDF)
Associate Prof. Xavier ROSSELLÓ, Spain.pdf (PDF)
Prof. Julie SANDERS, UK.pdf (PDF)
Mr. Richard STEPHENS, UK.pdf (PDF)
Prof. Felix C. TANNER, Switzerland.pdf (PDF)
Dr. Harriette VAN SPALL, Canada.pdf (PDF)
Dr. Alphons VINCENT, Medtronic.pdf (PDF)
Prof. Stephan WINDECKER, Switzerland.pdf (PDF)